Fidelity Investments’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Fidelity Investments’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,179,000	Closed	-$32M	–	2816
2015 Q4	$32M	Hold	1,179,000	–	–	﹤0.01%	1449
2015 Q3	$25.8M	Hold	1,179,000	–	–	﹤0.01%	1548
2015 Q2	$33.6M	Buy	1,179,000 +143,000	+14%	+$4.17M	﹤0.01%	1515
2015 Q1	$28.3M	Buy	1,036,000 +415,200	+67%	+$11.4M	﹤0.01%	1599
2014 Q4	$16.4M	Buy	620,800 +569,600	+1,113%	+$16.7M	﹤0.01%	1818
2014 Q3	$1.54M	Hold	51,200	–	–	﹤0.01%	2472
2014 Q2	$1.61M	Sell	51,200 -282,800	-85%	-$8.98M	﹤0.01%	2436
2014 Q1	$10.8M	Buy	334,000 +65,500	+24%	+$2.29M	﹤0.01%	1989
2013 Q4	$9.76M	Buy	+268,500	New	+$10.4M	﹤0.01%	1974
2013 Q3	–	Sell	-9,100	Closed	-$341K	–	2717
2013 Q2	$341K	Buy	+9,100	New	+$359K	﹤0.01%	2507

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments's MR Position: Q1 2016 in Review

Fidelity Investments sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 1,179,000 shares — an estimated $32M sold.

Fidelity Investments first reported a position in MR in Q2 2013 and held it in 10 quarters. The position peaked at $33.6M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Fidelity Investments reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Fidelity Investments sold 1,179,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $32M.
Fidelity Investments first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 10 quarters.
Fidelity Investments's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $33.6M in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Fidelity Investments's 13F filing for Q1 2016, filed 16 May 2016.